Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial

Yasuyuki Kakihana, Osamu Nishida, Takumi Taniguchi, Masaki Okajima, Hiroshi Morimatsu, Hiroshi Ogura, Yoshitsugu Yamada, Tetsuji Nagano, Eiichiro Morishima, Naoyuki Matsuda

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint Dive into the research topics of 'Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences